Bei Wang

Dr. Bei Wang

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2020 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
XHXiang Hong
Xiang Hong
PQPengfei Qin
Pengfei Qin
KHKaiping Huang
Kaiping Huang
XDXiaoling Ding
Xiaoling Ding
JMJun Ma
Jun Ma
BWBei Wang
Bei Wang

2 November 2022 in Environmental Research
Verified
Journal Article
Closed access
WWWei Wang
Wei Wang
XHXiang Hong
Xiang Hong
FZFanqi Zhao
Fanqi Zhao
JWJingying Wu
Jingying Wu
BWBei Wang
Bei Wang

1 February 2024 in Journal of Affective Disorders
Verified
Journal Article
Closed access
WWWeihao Wang
Weihao Wang
YLYuxiang Liu
Yuxiang Liu
DJDakang Ji
Dakang Ji
KXKaihong Xie
Kaihong Xie
YYYing Yang
Ying Yang
BWBei Wang
Bei Wang

8 July 2020 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
XHXiang Hong
Xiang Hong
JMJun Ma
Jun Ma
JYJiechen Yin
Jiechen Yin
SFShenghao Fang
Shenghao Fang
JGJia Geng
Jia Geng
BWBei Wang
Bei Wang

19 February 2019 in Epidemiology and Infection
Verified
Journal Article
Open access
PDF file
YYYueqi Yin
Yueqi Yin
YLYuxiang Liu
Yuxiang Liu
JZJing Zhu
Jing Zhu
XHXiang Hong
Xiang Hong
RYRui Yuan
Rui Yuan
BWBei Wang
Bei Wang
The aim of this meta-analysis was to provide a comprehensive overview of human immunodeficiency virus (HIV)-1 subtypes and to investigate temporal and geographical trends of the HIV-1 epidemic among men who have sex with men (MSM) in China. Chinese and English articles published between January 2007 and December 2017 were systematically searched. Pooled HIV-1 prevalence was calculated, and its stability was analysed using sensitivity analysis. Subgroups were based on study time period, sampling area and prevalence. Publication bias was measured using Funnel plot and Egger's test. A total of 68 independent studies that included HIV-1 molecular investigations were eligible for meta-analysis. Circulating recombinant form (CRF) 01_AE (57.36%, 95% confidence interval (CI) 53.76–60.92) was confirmed as the most prevalent HIV-1 subtype among MSM in China. Subgroup analysis for time period found that CRF01_AE steadily increased prior to 2012 but decreased during 2012–2016. Further whereas CRF07_BC increased over time, B/B′ decreased over time. CRF55_01B has increased in recent years, with higher pooled estimated rate in Guangdong (12.22%, 95% CI 10.34–13.17) and Fujian (8.65%, 95% CI 4.98–13.17) provinces. The distribution of HIV-1 subtypes among MSM in China has changed across different regions and periods. HIV-1 strains in MSM are becoming more complex. Long-term molecular monitoring in this population remains necessary for HIV-1 epidemic control and prevention.

23 April 2021 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
XHXiang Hong
Xiang Hong
PQPengfei Qin
Pengfei Qin
JYJiechen Yin
Jiechen Yin
YSYong Shi
Yong Shi
YXYan Xuan
Yan Xuan
BWBei Wang
Bei Wang
Background: Previous studies suggest that the vaginal microbiome is associated with polycystic ovary syndrome (PCOS). However, the clinical manifestations of PCOS are heterogeneous. Whether the vaginal microbiome is related with different clinical symptoms was unknown.Materials and Methods: In this cross-sectional study, 89 female patients with PCOS admitted to Zhongda Hospital (Nanjing, China) were included. Basic demographic information, health-related behaviors, clinical manifestations and sex hormone levels were comprehensively recorded for all patients. Vaginal swabs were acquired for microbiota sequencing of the V3–V4 region of the 16S rRNA gene.Results: The prevalence of bacterial vaginitis and vulvovaginal candidiasis was 15.7% and 13.5%, respectively, within the PCOS patients, which were the most important factors affecting the vaginal microbiome (permutational multivariate analysis of variance test, R2 = 0.108, P = 0.001). The vaginal microbiome was associated with specific clinical manifestations of PCOS, including acanthosis nigricans, intermenstrual bleeding, pregnancy history, testosterone level and anti-müllerian hormone level, with P values < 0.05. The abundance of Lactobacillus crispatus was higher (P = 0.010) while that of Lactobacillus iners was lower (P = 0.036) among PCOS patients with elevated testosterone levels. Other potential bacterial biomarkers were not statistically significant after adjusting for confounding factors. No evidence of associations of other common manifestations of PCOS, such as obesity and acne, with the vaginal microbiome was obtained.Conclusion: Vaginal bacterial species among PCOS patients with variable clinical manifestations, especially differences in testosterone levels, are distinct. Further studies are essential to investigate the microbiota and molecular mechanisms underpinning this disease.